Literature DB >> 33922702

Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer.

Akshara Singareeka Raghavendra1, Hala F Alameddine2, Clark R Andersen3, Jesse C Selber4, Abenaa M Brewster1, Carlos H Barcenas1, Abigail S Caudle5, Banu K Arun1, Debu Tripathy1, Nuhad K Ibrahim1.   

Abstract

(1) Background: The relatively high rate of contralateral prophylactic mastectomy (CPM) among women with early stage unilateral breast cancer (BC) has raised concerns. We sought to assess the influence of partners, physicians, and the media on the decision of women with unilateral BC to undergo CPM and identify clinicopathological variables associated with the decision to undergo CPM. (2) Patients and
Methods: Women with stage 0 to III unilateral BC who underwent CPM between January 2010 and December 2017. Patients were surveyed regarding factors influencing their self-determined decision to undergo CPM. Partner, physician, and media influence factors were modeled by logistic regressions with adjustments for a family history of breast cancer and pathological stage. (3)
Results: 397 (29.6%) patients completed the survey and were included in the study. Partners, physicians, and the media significantly influenced patients' decision to undergo CPM. The logistic regression models showed that, compared to self-determination alone, overall influence on the CPM decision was significantly higher for physicians (p = 0.0006) and significantly lower for partners and the media (p < 0.0001 for both). Fifty-nine percent of patients' decisions were influenced by physicians, 28% were influenced by partners, and only 17% were influenced by the media. The model also showed that patients with a family history of BC had significantly higher odds of being influenced by a partner than did those without a family history of BC (p = 0.015). (4) Conclusions: Compared to self-determination, physicians had a greater influence and partners and the media had a lower influence on the decision of women with unilateral BC to undergo CPM. Strong family history was significantly associated with a patient's decision to undergo CPM.

Entities:  

Keywords:  breast cancer; contralateral breast cancer; contralateral prophylactic mastectomy; unilateral breast cancer

Year:  2021        PMID: 33922702     DOI: 10.3390/cancers13092050

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  33 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

2.  Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance.

Authors:  Marlene H Frost; Jeffrey M Slezak; Nho V Tran; Constance I Williams; Joanne L Johnson; John E Woods; Paul M Petty; John H Donohue; Clive S Grant; Jeff A Sloan; Thomas A Sellers; Lynn C Hartmann
Journal:  J Clin Oncol       Date:  2005-10-03       Impact factor: 44.544

Review 3.  Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer.

Authors:  Abenaa M Brewster; Patricia A Parker
Journal:  Oncologist       Date:  2011-06-14

4.  Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.

Authors:  Isabelle Bedrosian; Chung-Yuan Hu; George J Chang
Journal:  J Natl Cancer Inst       Date:  2010-02-25       Impact factor: 13.506

5.  Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer.

Authors:  S K McDonnell; D J Schaid; J L Myers; C S Grant; J H Donohue; J E Woods; M H Frost; J L Johnson; D L Sitta; J M Slezak; T B Crotty; R B Jenkins; T A Sellers; L C Hartmann
Journal:  J Clin Oncol       Date:  2001-10-01       Impact factor: 44.544

Review 6.  Prophylactic mastectomy for the prevention of breast cancer.

Authors:  Liz Lostumbo; Nora E Carbine; Judi Wallace
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

7.  Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.

Authors:  Catherine Pesce; Erik Liederbach; Chihsiung Wang; Brittany Lapin; David J Winchester; Katharine Yao
Journal:  Ann Surg Oncol       Date:  2014-08-01       Impact factor: 5.344

8.  Positive, negative, and disparate--women's differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy.

Authors:  Andrea Altschuler; Larissa Nekhlyudov; Sharon J Rolnick; Sarah M Greene; Joann G Elmore; Carmen N West; Lisa J Herrinton; Emily L Harris; Suzanne W Fletcher; Karen M Emmons; Ann M Geiger
Journal:  Breast J       Date:  2008 Jan-Feb       Impact factor: 2.431

Review 9.  Shared decision making: a model for clinical practice.

Authors:  Glyn Elwyn; Dominick Frosch; Richard Thomson; Natalie Joseph-Williams; Amy Lloyd; Paul Kinnersley; Emma Cording; Dave Tomson; Carole Dodd; Stephen Rollnick; Adrian Edwards; Michael Barry
Journal:  J Gen Intern Med       Date:  2012-05-23       Impact factor: 5.128

Review 10.  Contralateral prophylactic mastectomy: current perspectives.

Authors:  Katharine Yao; Mark Sisco; Isabelle Bedrosian
Journal:  Int J Womens Health       Date:  2016-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.